View document text
Indraprastha Medical Corporation Limited
(Indraprastha Apollo Hospitals)
Regd. Office : Sarita Vihar, Delhi-Mathura Road, New Delhi – 110 076 (India)
Corporate Identity Number : L24232DL1988PLC030958
Phone:91-11-26925858,26925801,Fax: 91-11-26823629
E-mail: imclshares@apollohospitals.com, Website : https://www.apollohospitals.com/delhi/
Ref: IMCL/CS/BM/2026 6th August, 2026
The Manager The Manager
Listing Department Listing Department
BSE Limited Phiroze Jeejeebhoy National Stock Exchange of India Limite
Towers Dalal Street, Mumbai, Exchange Plaza, C-1, Block G,
Maharashtra - 400001 Bandra Kurla Complex, Bandra East,
Scrip Code: 532150 Mumbai, Maharashtra – 400051
Symbol: INDRAMEDCO
Re: Outcome of the Board Meeting held on 6th August, 2026
Dear Sir,
This is to inform that the Board of Directors of the Company has, at its meeting held on
Thursday, 6th August, 2026 (i.e. today), inter-alia, considered and approved the following
items:
1. The Un-audited Financial Results of the Company for the quarter ended 30th June,
2026.
Considered and approved the Un-audited Financial Results for the quarter ended 30th June,
2026, along with the Limited Review Report of the Statutory Auditors.
We are enclosing herewith the Un-audited Financial Results for the quarter ended 30th June,
2026, along with a copy of the Limited Review Report by the Statutory Auditors of the
Company – Annexure 1.
The above said documents are being posted on the website of the Company i.e.,
https://www.apollohospitals.com/delhi.
The financial results will also be published in the newspapers, in the format prescribed under
Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,
2015 (Listing Regulations).
2. Convening Annual General Meeting
Approved convening the thirty-eighth Annual General Meeting (AGM) of the Company, on
Thursday, 24th September, 2026, through video conferencing / other audio-visual means.
Indraprastha Medical Corporation Limited
(Indraprastha Apollo Hospitals)
Regd. Office : Sarita Vihar, Delhi-Mathura Road, New Delhi – 110 076 (India)
Corporate Identity Number : L24232DL1988PLC030958
Phone:91-11-26925858,26925801,Fax: 91-11-26823629
E-mail: imclshares@apollohospitals.com, Website : https://www.apollohospitals.com/delhi/
3. Fixation of Record Date
The Board has fixed the record date as Friday, 18th September, 2026, for the purpose of
determining the names of the shareholders who are entitled for the dividend for the year
2025-26 and also for the purpose of the Annual General Meeting.
4. Appointment of Cost Auditors
The Board, based on the recommendation of the Audit Committee, has approved the
Re-appointment of M/s Devarajan Swaminathan and Co. – Cost Accountants, as Cost
Auditors of the Company, for the financial year 2026-27.
Additional information as required under Regulation 30 of Listing Obligations is enclosed as
Annexure 2.
The Board meeting commenced at 3.00 p.m. and ended at 4.45 p.m.
This is for your information and record.
Thanking You,
Yours sincerely,
For Indraprastha Medical Corporation Limited
Priya Ranjan
AVP – Corporate Affairs & Legal
(Company Secretary & Compliance Officer)
Encl.: As above
Annexure 1
51-52, Sector 18, Phase-IV, Udyog Vihar,
Gurugram, Haryana 122015, India
Tel: +91 124 481 4444
Review Report on Unaudited Financial Results
To the Board of Directors of Indraprastha Medical Corporation Limited
1. We have reviewed the accompanying Statement of Unaudited Financial Results of Indraprastha Medical
Corporation Limited (“the Company”) for the quarter ended 30 June 2026 (“the Statement”), being submitted
by the Company pursuant to the requirements of Regulation 33 of the Securities and Exchange Board of India
(Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (‘the Listing Regulations’).
2. This Statement which is the responsibility of the Company’s management and approved by the Board of
Directors, has been prepared in accordance with the recognition and measurement principles laid down in
Indian Accounting Standard 34 ‘Interim Financial Reporting’ (‘Ind AS 34’) prescribed under Section 133 of the
Companies Act, 2013 (“the Act”), other accounting principles generally accepted in India and in compliance
with Regulation 33 of the Listing Regulations. Our responsibility is to express a conclusion on the Statement
based on our review.
3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE)
2410, ‘Review of Interim Financial Information Performed by the Independent Auditor of the Entity’, issued by
the Institute of Chartered Accountants of India. A review of interim financial information consists of making
inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and
other review procedures. A review is substantially less in scope than an audit conducted in accordance with
Standards on Auditing and consequently does not enable us to obtain assurance that we would become aware
of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.
4. Based on our review conducted as above, nothing has come to our attention that causes us to believe that the
accompanying Statement, prepared in accordance with the recognition and measurement principles laid down
in the aforesaid Ind AS and other accounting principles generally accepted in India, has not disclosed the
information required to be disclosed in terms of Regulation 33 of the Listing Regulations including the manner
in which it is to be disclosed, or that it contains any material misstatement.
For S N Dhawan & CO LLP
Chartered Accountants
Firm Registration No.: 000050N/N500045
Bhaskar Sen
Partner
Membership No.: 096985
UDIN: 26096985SAKEKX7709
Place: New Delhi
Date: 06 August 2026
S N Dhawan & CO LLP is registered with limited liability with identification number AAH-1125 and its registered office is 108, Mercantile House, 15, Kasturba Gandhi Marg, New Delhi 110001, India
INDRAPRASMTEHDAI CACLO RPORATILOINM ITED �A
Registoeffir:ceS eda rViithaaD re,lM hait huRroaaN de,w D el-h1i1 0076l ndraprastha
CorpoIrdaetneNt uimtby:e L r24232DL1988PLC0309A58 e��!.2
Phon9e1:- 11-269258F5a8x9,:1 -21619-2256880213,6 29 ' •'
E-maiimlc:l shares@apolWleobhsoihsttpeti:pt sa:l/s/.wcwowm.,a poUohospitals.com/delhi
StateomfUe nnatu diFtienda nRceisaufllo ttrsh Q eu aretnedre3 d0J un2e0,2 6
Amou(nRtis n c rore)
s. Quaretnedre d Yeaern ded
Particulars 30.06.23012.60 3.23002.60 6.23012.50 3.2026
(Unaudit(eAdu)d it(eUdn)a udi(tAeudd)i ted)
1 Revefnruoeom p erations 406.15 364.81 365.061 482.51
2 OLhienrc ome 8.42 7.33 6.90 28.75
3 Totianlc ome 414.57 372.14 371.961 511.26
4 Expenses
a)C osotfm atercioanlssu med 70.13 64.30 62.84 256.34
b)E mplobyeenee efixLpse nse 72.96 74.18 64.95 287.60
c)Profescshiaortngoade los c tors 111.15 96.59 97.84 389.39
d)Finacnocset s 1.65 1.49 1.56 6.02
c)Deprecainaadtm ioornl -isation expense 11.76 11.34 10.18 43.63
IO)lheexrp enses 72.10 69.23 66.28 282.26
Toteaxlp enses 33795 317.13 303.651 265.24
5 Probfeifteo xrcee ptioannatdla xi tems 74.82 55.01 68.31 246.02
6 Exceptiitoenmasl - - - -
7 Probfeiftto ar(xeP BT) 74.82 55.01 68.31 246.02
8 Taexx pense
CurrLeanxl 19.68 11.51 17.43 57.86
Defertraexd (0.71) 1.80 (0.58) 4.54
9 ProffoiUrt1 p ee riaofdtt ea(rxP AT) 55.85 41.70 51.46 183.62
10O thceorm prehienncsoimvee
(iH)emUs1 wailnl olbt er eclasLsopi rfooifreli dot s s 3.00 (1.52) 5.98 1.76
(iIin)colmarexe lattoii tnegUm 1swa itnl olbt er eclastsoified
(0.75) 0.38 (1.50) (0.44)
proofrli ots s
Totoatlhc eorm prehienncsoi(mvNeeeo tft aexx penses) 2.25 (1.14) 4.48 1.32
11T otcaolm prehienncsoifmvoteerh pee riod 58.10 40.56 55.94 184.94
12P aid-ups heaqcruaeip ti(ytF aavlca el Ruse1. 0 /e-ach) 91.67 91.67 91.67 91.67
13R ese(revxecsl Ruedvianlgu Raetsieoranvss e hso)wi nnt he
648.70
audibtaelda snhceoeef pt r eviyoeuasr
EarninpPes.rhs a Braesa incDd i lu(lRes-dN. o)At 1 mualised 6.09 4.55 5.6
[Showing first 8,000 characters — download PDF for full document]